Lantheus Holdings (LNTH) Enterprise Value (2014 - 2026)
Lantheus Holdings (LNTH) posted quarterly Enterprise Value of -$498.6 million for Q1 2026, up 46.88% year-over-year from -$339.5 million in Q1 2025, and down 38.83% quarter-over-quarter from -$359.1 million in Q4 2025.
Lantheus Holdings (LNTH) Enterprise Value (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported Enterprise Value for 13 consecutive years, with -$498.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Enterprise Value rose 46.88% year-over-year to -$498.6 million; the TTM figure through Mar 2026 stood at -$498.6 million (up 46.88% YoY), while the FY2025 annual figure was -$359.1 million, up 60.66% from the prior year.
- Enterprise Value slipped to -$498.6 million in Q1 2026 per LNTH's latest filing, from -$359.1 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$105.4 million in Q1 2022 and bottomed at -$938.5 million in Q1 2025.
- Historically, Enterprise Value has averaged -$546.5 million across 5 years, with a median of -$498.6 million in 2026.
- Annual changes were most pronounced in 2023 — Enterprise Value sank 346.93% — and 2025, when it soared 60.66%.
- Lantheus Holdings' Enterprise Value stood at -$415.7 million in 2022, then slumped by 71.7% to -$713.7 million in 2023, then fell by 27.91% to -$912.8 million in 2024, then jumped by 60.66% to -$359.1 million in 2025, then slumped by 38.83% to -$498.6 million in 2026.
- Business Quant data shows LNTH's Enterprise Value at -$498.6 million in Q1 2026, -$359.1 million in Q4 2025, and -$382.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | -164.00 Mn |
| 10 | Lantheus Holdings | 6.54 Bn | 5.94 Bn | 241.86 Mn | -593.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -593.30 Mn |
| Mar 31, 2026 | -498.58 Mn |
| Dec 31, 2025 | -359.12 Mn |
| Sep 30, 2025 | -382.01 Mn |
| Jun 30, 2025 | -695.57 Mn |
| Mar 31, 2025 | -938.53 Mn |
| Dec 31, 2024 | -912.81 Mn |
| Sep 30, 2024 | -866.39 Mn |
| Jun 30, 2024 | -757.02 Mn |
| Mar 31, 2024 | -718.28 Mn |
| Dec 31, 2023 | -713.66 Mn |
| Sep 30, 2023 | -614.13 Mn |
| Jun 30, 2023 | -414.08 Mn |
| Mar 31, 2023 | -470.86 Mn |
| Dec 31, 2022 | -415.65 Mn |
| Sep 30, 2022 | -257.26 Mn |
| Jun 30, 2022 | -171.43 Mn |
| Mar 31, 2022 | -105.36 Mn |
| Dec 31, 2021 | -98.51 Mn |
| Sep 30, 2021 | -91.48 Mn |